Published April 27, 2018
| Version v1
Dataset
Open
The process of HDAC11 Assay Development: time-course study follow-up-effect of additives
Description
Since the activity of HDAC11 has been observed to be quite low as per the previous data, a preliminary test was performed to check any drastic increase in the activity in the presence of an additive.
Notes
The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
27april2018-additives.pdf
Files
(185.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:2839deb365692cb80b286ccf0fefc962
|
185.1 kB | Preview Download |